Finding Description
Based on observation, interview, record review, and facility policy review, the facility failed to ensure a significant medication error did not occur when a nurse administered a routine dose of insulin three (3) hours past the prescribed time without notifying the physician for one (1) of six (6) residents reviewed for medication administration, Resident #32.
Findings included:
A review of the facility's policy, Medication Administration, dated 9/20/2019, revealed, .Policy Explanation and Compliance Guidelines .11. Compare medication source with MAR (Medication Administration Record) .b. Administer within 60 minutes prior to or after scheduled time unless otherwise ordered by physician .
On 4/14/25 at 11:30 AM, during an observation of medication administration, Licensed Practical Nurse (LPN) #3 administered thirty (30) units of Basaglar (a type of insulin) to Resident #32 in the left upper abdomen.
On 4/17/25 at 12:12 PM, during an interview with LPN #3, she confirmed she administered thirty (30) units of Basaglar at 11:30 AM on 4/14/25. LPN #3 explained she was behind in giving medications because she was a contract nurse, and this was her first day at the facility. She stated she was aware the medication was due at 8:00 AM and acknowledged this could result in elevated blood glucose levels.
On 4/17/25 at 12:25 PM, during an interview with the Director of Nursing (DON), she confirmed the nurse failed to follow the facility's medication administration policy. The DON explained the policy requires medications to be administered within one (1) hour before or after the scheduled time. She stated the nurse should have requested assistance if she was falling behind and should have notified the physician that the routine dose of Basaglar was given late at 11:30 AM.
On 4/17/25 at 12:33 PM, during an interview with the Medical Doctor (MD), she stated she expected staff to administer medications as ordered. She explained that if medications cannot be administered as ordered, staff should notify the DON, who would notify her. She further stated late administration of insulin could cause elevated blood glucose levels.
On 4/17/25 at 1:29 PM, during an interview with the Administrator, she stated she expected staff to follow the physician's orders and the facility's medication administration policy.
A record review of the admission Record revealed the facility admitted Resident #32 on 8/2/24 with diagnoses including Diabetes Mellitus.
A record review of the resident's Quarterly Minimum Data Set (MDS) with an Assessment Reference Date (ARD) of 2/6/25 revealed a Brief Interview for Mental Status (BIMS) score of 4, which indicated the resident's cognition was severely impaired.
A record review of the Order Summary Report revealed a physician's order dated 3/21/25 for Basaglar KwikPen subcutaneous solution: Inject 30 units subcutaneously in the morning related to Type 2 Diabetes Mellitus .
A record review of the April 2025 Medication Administration Record (MAR) revealed LPN #3 documented that thirty (30) units of Basaglar were administered at 8:00 AM on 4/14/25.
Findings included:
A review of the facility's policy, Medication Administration, dated 9/20/2019, revealed, .Policy Explanation and Compliance Guidelines .11. Compare medication source with MAR (Medication Administration Record) .b. Administer within 60 minutes prior to or after scheduled time unless otherwise ordered by physician .
On 4/14/25 at 11:30 AM, during an observation of medication administration, Licensed Practical Nurse (LPN) #3 administered thirty (30) units of Basaglar (a type of insulin) to Resident #32 in the left upper abdomen.
On 4/17/25 at 12:12 PM, during an interview with LPN #3, she confirmed she administered thirty (30) units of Basaglar at 11:30 AM on 4/14/25. LPN #3 explained she was behind in giving medications because she was a contract nurse, and this was her first day at the facility. She stated she was aware the medication was due at 8:00 AM and acknowledged this could result in elevated blood glucose levels.
On 4/17/25 at 12:25 PM, during an interview with the Director of Nursing (DON), she confirmed the nurse failed to follow the facility's medication administration policy. The DON explained the policy requires medications to be administered within one (1) hour before or after the scheduled time. She stated the nurse should have requested assistance if she was falling behind and should have notified the physician that the routine dose of Basaglar was given late at 11:30 AM.
On 4/17/25 at 12:33 PM, during an interview with the Medical Doctor (MD), she stated she expected staff to administer medications as ordered. She explained that if medications cannot be administered as ordered, staff should notify the DON, who would notify her. She further stated late administration of insulin could cause elevated blood glucose levels.
On 4/17/25 at 1:29 PM, during an interview with the Administrator, she stated she expected staff to follow the physician's orders and the facility's medication administration policy.
A record review of the admission Record revealed the facility admitted Resident #32 on 8/2/24 with diagnoses including Diabetes Mellitus.
A record review of the resident's Quarterly Minimum Data Set (MDS) with an Assessment Reference Date (ARD) of 2/6/25 revealed a Brief Interview for Mental Status (BIMS) score of 4, which indicated the resident's cognition was severely impaired.
A record review of the Order Summary Report revealed a physician's order dated 3/21/25 for Basaglar KwikPen subcutaneous solution: Inject 30 units subcutaneously in the morning related to Type 2 Diabetes Mellitus .
A record review of the April 2025 Medication Administration Record (MAR) revealed LPN #3 documented that thirty (30) units of Basaglar were administered at 8:00 AM on 4/14/25.